Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus

New England Journal of Medicine

Volumn 361, Issue 20, 2009, Pages 1945-1952

  Hancock, Kathy ^a   Veguilla, Vic ^a   Lu, Xiuhua ^a   Zhong, Weimin ^a   Butler, Eboneé N ^a   Sun, Hong ^a   Liu, Feng ^a   Dong, Libo ^a   DeVos, Joshua R ^b   Gargiullo, Paul M ^a   Brammer, T Lynnette ^a   Cox, Nancy J ^a   Tumpey, Terrence M ^a   Katz, Jacqueline M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; INFLUENZA VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; GROUPS BY AGE; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; PANDEMIC; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CROSS REACTIONS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; YOUNG ADULT;

EID: 70349873173     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0906453     Document Type: Article

References (27)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615 [Erratum, N Engl J Med 2009;361:102.]
2. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201.
3. Newman AP, Reisdorf E, Beinemann J, et al. Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin. Emerg Infect Dis 2008;14: 1470-1472
4. Shinde V, Bridges CB, Uyeki TM, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009;360:2616-2625 [Erratum, N Engl J Med 2009;361:102.]
5. Nelson MI, Viboud C, Simonsen L, et al. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 2008;4(2): e1000012.
6. Dowdle WR. Pandemic influenza: confronting a re-emergent threat: the 1976 experience. J Infect Dis 1997;176:Suppl 1: S69-S72.
7. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58:521-524
8. Marine WM, Thomas JE. Age-related response to 1000 CCA unit zonally purified, inactivated influenza vaccines in volunteers in the U.S.A. Postgrad Med J 1973; 49:164-168
9. Kendal AP, Pereira MS, Skehel JJ. Concepts and procedures for laboratory-based influenza surveillance. Atlanta: Centers for Disease Control, 1982.
10. Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999;37:937-943 (Pubitemid 29140593)
11. de Jong JC, Palache AM, Beyer WEP, Rimmelzwaan GF, Boon ACM, Osterhaus ADME. Haemagglutination-inhibiting antibodies to influenza virus. Dev Biol (Basel) 2003;115:63-73.
12. Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979;35:69-75.
13. Fox JP, Hall CE, Cooney MK, Foy HM. Influenza virus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol 1982;116:212-227
14. Sasaki S, Jaimes MC, Holmes TH, et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 2007;81:215-228 (Pubitemid 44975162)
15. Sencer DJ, Millar JD. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 2006;12:29-33.
16. Massicot J, Murphy BR. Comparison of the hemagglutination-inhibiting and neutralizing antibody responses of volunteers given 400 chick cell-agglutinating units of influenza A/New Jersey/76 splitvirus vaccine. J Infect Dis 1977;136:Suppl: S472-S474. (Pubitemid 8293891)
17. Leroux-Roels I, Bernhard R, Gérard P, Drame M, Hanon E, Leroux-Roels G. Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. PLoS One 2008;3(2):e1665. (Pubitemid 351865662)
18. Stephenson I, Bugarini R, Nicholson KG, et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59- adjuvanted influenza A/Duck/Singapore/ 97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 2005;191:1210-1215 (Pubitemid 40503646)
19. Stephenson I, Nicholson KG, Hoschler K, et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N Engl J Med 2008;359:1631-1633
20. Davenport FM, Hennessy AV, Francis T Jr. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med 1953;98:641-656
21. Shope RE. The incidence of neutralizing antibodies for swine influenza virus in the sera of human beings of different ages. J Exp Med 1936;63:669-684
22. Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci 2001;356:1829-1839
23. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A 2004;101:3166-3171
24. Cuneo-Crovari P, Gasparini R, Pellegrino C. Sero-epidemiological survey on human and swine influenza A: situation at the onset of summer 1976. Boll Ist Sieroter Milan 1976;55:463-470
25. Yu X, Tsibane T, McGraw PA, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 2008;455:532-536
26. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021-1025
27. Rimmelzwaan GF, McElhaney JE. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008;26: Suppl 4:D41-D44.